Imaging of Brain Remodeling and Functional Recovery
大脑重塑和功能恢复的成像
基本信息
- 批准号:7252234
- 负责人:
- 金额:$ 46.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-04-01 至 2012-03-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAgeAnimalsAnisotropyAreaBlood VesselsBlood VolumeBrain imagingCerebrovascular CirculationCerebrumCyclic GMPDataDevelopmentDiagnosticDiseaseElderlyEventFerritinFundingGleanGoalsHistocytochemistryHistologyHumanImageImmunohistochemistryLaser Scanning Confocal MicroscopyLasersLeadMagnetic Resonance ImagingMeasurementMeasuresMethodsMonitorNervous System PhysiologyNeurodegenerative DisordersNeuronsOutcomePatientsPredispositionRattusRecoveryRecovery of FunctionResearchScanningStrokeStructureTherapeuticThinkingTissuesTransgenesTreatment ProtocolsVascular PermeabilitiesVascular remodelingWeightagedangiogenesisbasebehavior testbrain tissuedensityfunctional outcomesimprovedindexinginhibitor/antagonistinnovationnerve injuryneuroblastneurorestorationnovelphosphoric diester hydrolasepost strokerestorative treatmentsildenafilstroke recoverytool
项目摘要
The objective of this project is to develop magnetic resonance imaging (MRI) as a tool to non-
invasively evaluate and monitor recovery in stroke patients. Our studies during the current funding
period indicate that certain agents can enhance functional recovery after stroke in experimental
animals based on histological and functional assessments. A prime candidate among restorative
agents is sildenafil, a phosphodiesterase type-5 inhibitor, which has been widely used in humans
to increase cyclic guanosine monophosphate (cGMP). Our data show that sildenafil significantly
improves functional recovery in both young and aged animals after stroke. Hence, we will employ
sildenafil in the proposed studies. We have also generated preliminary imaging data, which
indicate that certain MRI methods may be sensitive to post-stroke tissue remodeling (vascular
and neuronal) events that are thought to influence eventual outcome. The studies proposed in the
current application expand on this theme by combining and applying these novel imaging,
histological and restorative treatment strategies to assess post-stroke vascular (Aim 1) and
neuronal (Aim 2) remodeling in both young and aged animals with and without restorative
therapy. MRI will be used to identify, characterize and define tissue-remodeling events that
contribute to improvement of late-term functional outcome after stroke. These MRI assessments
will be compared and correlated to corresponding measures of tissue remodeling determined
from 3D laser scanning confocal microscopy and immunohistochemistry. Finally, Aim 3 will study
the relationship between the various MRI and histological indices of neuronal and vascular
remodeling and will relate these data to functional outcome as measured by a battery of
behavioral tests. The proposed studies are novel and innovative, moving our research away from
acute diagnostics and neuroprotective therapeutic approaches for stroke treatment and toward a
relatively unexplored area of late-term restorative therapy that promotes brain tissue remodeling
events that ultimately improve functional outcome. If successful, these studies are expected to
generate ground breaking information about post-stroke brain tissue remodeling that will be useful
for monitoring stroke recovery and may lead to optimization of treatment protocols that would
benefit all stroke patients.
该项目的目标是开发磁共振成像(MRI)作为一种工具来非
有创评估和监测中风患者的康复情况。我们在当前资助期间的研究
实验表明,某些药物可以增强中风后的功能恢复
基于组织学和功能评估的动物。恢复性的主要候选人
西地那非是一种5型磷酸二酯酶抑制剂,已广泛应用于人类
增加环磷酸鸟苷 (cGMP)。我们的数据显示西地那非显着
改善中风后年轻和老年动物的功能恢复。因此,我们将雇用
拟议研究中的西地那非。我们还生成了初步成像数据,
表明某些 MRI 方法可能对中风后组织重塑(血管
和神经元)被认为影响最终结果的事件。中提出的研究
当前的应用通过结合和应用这些新颖的成像来扩展这个主题,
评估中风后血管的组织学和恢复性治疗策略(目标 1)和
在有或没有恢复的情况下,年轻和年老动物的神经元(目标 2)重塑
治疗。 MRI 将用于识别、表征和定义组织重塑事件
有助于改善中风后的远期功能结果。这些 MRI 评估
将与确定的组织重塑的相应测量值进行比较和关联
来自 3D 激光扫描共焦显微镜和免疫组织化学。最后,目标3将学习
神经元和血管的各种MRI与组织学指标之间的关系
重塑并将这些数据与通过一组测量的功能结果相关联
行为测试。拟议的研究新颖且具有创新性,使我们的研究远离
中风治疗的急性诊断和神经保护治疗方法
促进脑组织重塑的后期恢复治疗相对尚未探索的领域
最终改善功能结果的事件。如果成功的话,这些研究预计将
生成有关中风后脑组织重塑的突破性信息,这将是有用的
用于监测中风恢复并可能导致治疗方案的优化
造福所有中风患者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
QUAN JIANG其他文献
QUAN JIANG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('QUAN JIANG', 18)}}的其他基金
Glymphatic and cognitive impairment of aging and diabetes
衰老和糖尿病导致的类淋巴和认知障碍
- 批准号:
9428053 - 财政年份:2017
- 资助金额:
$ 46.18万 - 项目类别:
Imaging Cell Based Treatment of Traumatic Brain Injury
基于细胞成像的脑外伤治疗
- 批准号:
8466385 - 财政年份:2011
- 资助金额:
$ 46.18万 - 项目类别:
Imaging Cell Based Treatment of Traumatic Brain Injury
基于细胞成像的脑外伤治疗
- 批准号:
8184116 - 财政年份:2011
- 资助金额:
$ 46.18万 - 项目类别:
Imaging Cell Based Treatment of Traumatic Brain Injury
基于细胞成像的脑外伤治疗
- 批准号:
8664446 - 财政年份:2011
- 资助金额:
$ 46.18万 - 项目类别:
Imaging Cell Based Treatment of Traumatic Brain Injury
基于细胞成像的脑外伤治疗
- 批准号:
8272524 - 财政年份:2011
- 资助金额:
$ 46.18万 - 项目类别:
In vivo MR Evaluation of Cell Therapy for Stroke
中风细胞疗法的体内 MR 评估
- 批准号:
7341707 - 财政年份:2004
- 资助金额:
$ 46.18万 - 项目类别:
In vivo MR Evaluation of Cell Therapy for Stroke
中风细胞疗法的体内 MR 评估
- 批准号:
7156953 - 财政年份:2004
- 资助金额:
$ 46.18万 - 项目类别:
In vivo MR Evaluation of Cell Therapy for Stroke
中风细胞疗法的体内 MR 评估
- 批准号:
6871428 - 财政年份:2004
- 资助金额:
$ 46.18万 - 项目类别:
In vivo MR Evaluation of Cell Therapy for Stroke
中风细胞疗法的体内 MR 评估
- 批准号:
7560378 - 财政年份:2004
- 资助金额:
$ 46.18万 - 项目类别:
In vivo MR Evaluation of Cell Therapy for Stroke
中风细胞疗法的体内 MR 评估
- 批准号:
6986084 - 财政年份:2004
- 资助金额:
$ 46.18万 - 项目类别:
相似国自然基金
粪便mtDNA异质性特征及其在哺乳动物年龄估算中的意义
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:面上项目
EEDA在RPE细胞中的功能及其在年龄相关性视网膜病变中的机制研究
- 批准号:81770946
- 批准年份:2017
- 资助金额:56.0 万元
- 项目类别:面上项目
sFlt-1基因靶向敲除诱导鼠新生血管性眼底病及其机制的实验研究
- 批准号:81271016
- 批准年份:2012
- 资助金额:60.0 万元
- 项目类别:面上项目
Robo4基因敲除诱导小鼠年龄相关性视网膜变性及机制研究
- 批准号:81170853
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
siRNA沉默蛋白酶体β亚基基因诱导小鼠年龄相关性黄斑变性及其分子机制的研究
- 批准号:81000390
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
A Refined Murine Model of Post-sepsis Cognitive Impairment for Investigating Mitochondrial Abnormalities and Human ApoE4 Gene Polymorphisms
用于研究线粒体异常和人类 ApoE4 基因多态性的精制脓毒症后认知障碍小鼠模型
- 批准号:
10646579 - 财政年份:2023
- 资助金额:
$ 46.18万 - 项目类别:
Recruitment of Cerebellar Circuits with Balance Training for Cognitive Rehabilitation in a Mouse Model of Mild Traumatic Brain Injury
在轻度创伤性脑损伤小鼠模型中通过平衡训练募集小脑回路进行认知康复
- 批准号:
10753349 - 财政年份:2023
- 资助金额:
$ 46.18万 - 项目类别:
Novel Combinations of Natural Product Compounds for Treatment of Alzheimer Disease and Related Dementias
用于治疗阿尔茨海默病和相关痴呆症的天然产物化合物的新组合
- 批准号:
10603708 - 财政年份:2023
- 资助金额:
$ 46.18万 - 项目类别:
Development of Antisense Oligonucleotides to Regulate Gamma' Fibrinogen Levels
开发反义寡核苷酸来调节γ纤维蛋白原水平
- 批准号:
10759950 - 财政年份:2023
- 资助金额:
$ 46.18万 - 项目类别: